Z-2791-2016 Class II Terminated

Recalled by Stryker Howmedica Osteonics Corp. — Mahwah, NJ

FDA device recall Z-2791-2016 was initiated by Stryker Howmedica Osteonics Corp. on Jun 30, 2016 and is designated Class II. Reason for recall: Stryker discovered that a Tibial Nail and femoral Nail were incorrectly labeled and distributed to the field. The recall status is terminated (terminated Jun 21, 2017). Affected quantity: 1 unit in total.

Recall details

Product Type
Devices
Report Date
Sep 21, 2016
Initiation Date
Jun 30, 2016
Termination Date
Jun 21, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 unit in total

Product description

Supracondylar Nail T2 SCN 09x300 mm T2 Supracondylar Nail System is intended to provide strong and stable internal fixation with minimal soft tissue irritation of the distal femur. (1( Open and closed femoral fractures, (2) Pseudoarthrosis and correction osteotomy, (3) Pathologic fractures, impending pathologic fractures, and tumor resections, (4) Supracondylar fractures, including those with intra-articular extension, (5) Fractures distal to a Total Hip Prosthesis and (6) Non-unions and malunions

Reason for recall

Stryker discovered that a Tibial Nail and femoral Nail were incorrectly labeled and distributed to the field.

Distribution pattern

US distribution to state of: CA.

Code information

Catalog number 18220930S and Lot Code K836729

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2791-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2791-2016. Report a data issue: hello@regdatalab.com.